Forward PE Ratio: 9.51
The forward PE ratio is 9.51 as of Thursday, July 9, 2026.
Forward PE Ratio (9.51) = Close Price ($291.80) / Consensus Forward EPS ($30.45)
CI Forward PE Ratio Metrics
FORWARD PE RATIO
9.51
CI Competitors' Forward PE Ratio
Cigna Corporation
Market Cap
$77.19B
Forward PE Ratio
9.51
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cigna Corporation (CI) | $77.19B | 9.51 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $68.81B | 14.31 |
| Boston Scientific Corporation (BSX)vs › | $66.87B | 13.33 |
| HCA Healthcare, Inc. (HCA)vs › | $90.73B | 13.58 |
| Elevance Health Inc. (ELV)vs › | $91.29B | 15.46 |
| McKesson Corporation (MCK)vs › | $92.82B | 20.99 |
| Cencora, Inc. (COR)vs › | $58.85B | 17.41 |
| Cardinal Health, Inc. (CAH)vs › | $54.75B | 22.02 |
| Becton, Dickinson and Company (BDX)vs › | $54.65B | 11.96 |
| Edwards Lifesciences Corporation (EW)vs › | $52.59B | 31.10 |
Trailing vs Forward
Trailing P/E
12.3
reported TTM EPS
Forward P/E
9.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $30.45 implies +29.1% EPS growth vs the reported trailing $23.58.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $291.80 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $30.45 | $30.28 – $30.64 | 14 | 9.6x |
| 2027-12-31 | $33.43 | $32.44 – $34.14 | 14 | 8.7x |
| 2028-12-31 | $36.85 | $29.71 – $44.04 | 8 | 7.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Cigna Corporation (CI)?
- The forward PE ratio for CI stock is 9.51.
Related Metrics
About Cigna Corporation
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- David Michael Cordani